595 related articles for article (PubMed ID: 16550383)
41. Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints.
Van Der Gucht A; Verger A; Yagdigul Y; Poussier S; Joly L; Watfa G; Benetos A; Karcher G; Marie PY
Acta Radiol; 2015 Aug; 56(8):980-9. PubMed ID: 25085109
[TBL] [Abstract][Full Text] [Related]
42. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
Zhou Y; Yu F; Duong TQ;
J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
[TBL] [Abstract][Full Text] [Related]
43. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
[TBL] [Abstract][Full Text] [Related]
44. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
Mosconi L; Tsui WH; De Santi S; Li J; Rusinek H; Convit A; Li Y; Boppana M; de Leon MJ
Neurology; 2005 Jun; 64(11):1860-7. PubMed ID: 15955934
[TBL] [Abstract][Full Text] [Related]
45. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
[TBL] [Abstract][Full Text] [Related]
46. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW;
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905
[TBL] [Abstract][Full Text] [Related]
47. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
48. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
Ng S; Villemagne VL; Berlangieri S; Lee ST; Cherk M; Gong SJ; Ackermann U; Saunder T; Tochon-Danguy H; Jones G; Smith C; O'Keefe G; Masters CL; Rowe CC
J Nucl Med; 2007 Apr; 48(4):547-52. PubMed ID: 17401090
[TBL] [Abstract][Full Text] [Related]
49. Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.
Karow DS; McEvoy LK; Fennema-Notestine C; Hagler DJ; Jennings RG; Brewer JB; Hoh CK; Dale AM;
Radiology; 2010 Sep; 256(3):932-42. PubMed ID: 20720076
[TBL] [Abstract][Full Text] [Related]
50. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
[TBL] [Abstract][Full Text] [Related]
51. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
[TBL] [Abstract][Full Text] [Related]
52. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Yanase D; Matsunari I; Yajima K; Chen W; Fujikawa A; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):794-805. PubMed ID: 15759148
[TBL] [Abstract][Full Text] [Related]
53. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
54. Brain fluorodeoxyglucose (FDG) PET in dementia.
Kato T; Inui Y; Nakamura A; Ito K
Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
[TBL] [Abstract][Full Text] [Related]
55. Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
Jing J; Zhang F; Zhao L; Xie J; Chen J; Zhong R; Zhang Y; Dong C
J Alzheimers Dis; 2021; 79(3):1317-1325. PubMed ID: 33427748
[TBL] [Abstract][Full Text] [Related]
56. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
Gutierrez D; Montandon ML; Assal F; Allaoua M; Ratib O; Lövblad KO; Zaidi H
Comput Med Imaging Graph; 2012 Dec; 36(8):610-9. PubMed ID: 23046730
[TBL] [Abstract][Full Text] [Related]
57. The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.
Rice L; Bisdas S
Eur J Radiol; 2017 Sep; 94():16-24. PubMed ID: 28941755
[TBL] [Abstract][Full Text] [Related]
58. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
59. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.
Yan S; Zheng C; Cui B; Qi Z; Zhao Z; An Y; Qiao L; Han Y; Zhou Y; Lu J
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2440-2452. PubMed ID: 32157432
[TBL] [Abstract][Full Text] [Related]
60. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
Brugnolo A; De Carli F; Pagani M; Morbelli S; Jonsson C; Chincarini A; Frisoni GB; Galluzzi S; Perneczky R; Drzezga A; van Berckel BNM; Ossenkoppele R; Didic M; Guedj E; Arnaldi D; Massa F; Grazzini M; Pardini M; Mecocci P; Dottorini ME; Bauckneht M; Sambuceti G; Nobili F
J Alzheimers Dis; 2019; 68(1):383-394. PubMed ID: 30776000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
